Fakta leverer revisjon og utvidede regnskap- og rådgivningstjenester. Vi holder til i Solheimsviken 15B, Beddingen på Danmarksplass. Vår filosofi er å være et frittstående, lokalt selskap som leverer høy kvalitet med spisskompetanse som du kan stole på.I Fakta er vi opptatt av å ha nærhet til våre kunder på Vestlandet. Lokal forankring og uavhengighet gir oss i mange tilfeller muligheten til å tilby tjenester til en mer konkurransedyktig pris. Vi har oppdragsgivere innen et stort spekter av norsk næringsliv, og vi dekker behovene til mindre bedrifter så vel som større, børsnoterte selskaper.Etter betydelig vekst er vi nå ca 26 meget kompetente fagpersoner. For å holde tritt med utviklingen er våre tjenester i kontinuerlig utvikling og forbedring. Dette gjør oss til den aktive sparringspartneren du kan diskutere løsninger med og som gir deg gode råd når du trenger det.

Sijabra is Norways first "One-Stop-Shop for wedding" and offer customer free use of finding vendors, different suppliers for there wedding. Chat online with your vendors, get ratings and references to build your credibility in the system. Sijabra provides all vendors from venues, ceremony, photographer and many many more. As a user you will also with time, take action in our new seating planning tools, budget, picture sharing, giftlist, travels and more exiting friend and guest listing.

Alfa Audio Solutions AS is a competitive service-oriented company with long and solid experience in audiovisual solutions. With over 30 years of work in this field, we offer smart, user-friendly and reliable AV solutions, focusing on customer needs and wishes. Our services are aimed at businesses, businesses and the private market. We offer everything from simple installations to complex meeting room solutions. Video conferencing systems with Skype for Business, information screens and digital signage for your advertising message. Interactive tables for teaching and classrooms.

S:mart hjelper i dag over 100 arbeidsplasser med en fleksibel løsning som alltid sørger for å ha et godt mat- og drikketilbud til sine ansatte - ferdige lunsjer, møtemat, overtidsmat, snacks og drikke tilgjengelig gjennom uken. Flere lunsjprodusenter De ansatte bestiller det de ønsker (fast) levering på fra et stort utvalg av baguetter, salater, wraps o.l. i webshop, https://nettbutikk.s-mart.no/products Null administrasjon Bedriften velger prisen de ansatte skal kjøpe produktene for i S:mart-appen, fra kr 0 til fullpris. Ved at den ansatte betaler sin egenandel med appen, slipper dere både lønnstrekk og fordelsbeskatning. Bedrift mottar faktura for bestilte varer minus det de ansatte betaler i appen. Maten leveres enkelt før lunsj til S:mart-kjøleskapet. Alltid noe tilgjengelig Vi kan også sørge for at S:mart-kjøleskapet blir fylt opp av småmåltider, snacks, og drikke som de ansatte kan kjøpe fra med S:mart-appen. Dere bestemmer prisen på produktene. S:mart, jo! Vil du vite mer om S:mart - ta kontakt med oss på hei@s-mart.no eller ta en titt på hjemmesiden vår www.s-mart.no.

Taking New tec in use, performing high-quality ROV inspections With an agile an compact system. Development of New tec for the aquaculture industry. NMS is a voluntary organization, rooted in The Church of Norway. NMS comprises volunteers and congregations who volunteer, pray, donate and collect money for our work. In addition, NMS has staff in Norway and abroad who work to give people a dignified life and lasting hope.

Ose Water AS is a Norwegian bottled water and bag-in-box water producer.The water source is Ose which provides high quality natural mineral water. The company aim to be in production for international sale in Q1 2019. Ose Water AS is a producer of natural mineral water from the Ose spring in Bygland municipality, Aust-Agder county in Norway.

Visito AS er en Bergensbasert IT-virksomhet med erfarne konsulenter som jobber i grensesnittet mellom teknologi og forretning. Vi hjelper kundene våre med å levere viktige prosjekter på en smidig og effektiv måte, og med riktig nivå av kvalitet. Våre tjenester inkluderer teknisk prosjektledelse, rådgivning, arkitektur, infrastruktur og kvalitetssikring. Vi opptrer profesjonelt og med en åpen, uformell og inkluderende tilnærming. Vi har høye krav til integritet og ryddighet.

Myldring skaper møteplasser. Vi er arrangører, regissører, tekniske tilretteleggere for møteplasser der ideer og kunnskap er fellesnevneren. Målet vårt er å legge tilrette for flere tankevekkere og interessante koblinger. Noen av møteplassene arrangerer vi selv. Som Stormkast, konferansen om morgendagens industrielle muligheter. Eller Substans - den ettertenksomme møteplassen om teknologi, landbruksteknologi-samlingen Beit. Og innovasjonsmønstringen NuWave.I tillegg påtar vi oss ansvar for andres arrangement. Å være godt vertskap og skape gode rammer er et fag. Det å få teknikken til å fungere kan være avgjørende. Å lage gode video-opptak kan mangedoble verdien av den kunnskapen som formidles fra scenen. Vi jobber kollaborativt. Vi tror på gode partnerskapsmodeller. Derfor jobber vi sammen med flinke underleverandører. Vi prøver å skape sponsormodeller og partnerskap som skaper vinn-vinn. Målet vårt er å skape nettverk. Få koblet sammen ulike fagmiljøer. Løfte blikket. Gjøre verden litt mer interessant.

On a mission to help professional writers use clearer language In 2014, we started our journey to create a world-class writing assistant based on deep learning. Freelancers, Journalists, marketing, public servants, and others can lift their relevance, target precision, and message clarity using Upfeed’s AI-driven writing assistant.

ENVE leverer morgendagens datarom for sømløse og effektive transaksjoner. Ved blant annet automatisering av rapportgenerering og optimalisering av informasjonsflyt tilbyr vi våre kunder et markedsledende arbeidsverktøy for due diligence-prosesser og transaksjoner. ENVE skal gå i bresjen for å bidra til digitalisering og modernisering av transaksjonsmarkedet.

Move is an IT infrastructure consulting company and system integrator covering the areas of Network and Security, Virtualization, Database and OS platforms, and high-end server/storage. Move delivers: High expertise advisor and consultancy services Design and implementation of complex projects Diversified service and support services Project Management IT-solutions

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Jeg har jobbet innenfor biologisk medisin i 25 år.Vi har funnet et egnet sted i Sverige for å drive HELSE FARM med mange mulige aktiviteter...nære Oslo. Dersom du har "helsetanker" i forbindelse med dine innvesteringer, kontakt meg !TOTAL INVESTERING I DETTE PROSJEKTET ER 9 MILL NOKTa gjerne kontakt!CARL-ERIK FARNES90677330cefarnes@gmail.com